GPER1 and breast carcinoma: Our previous study demonstrated that GPER-mediated PI3K/AKT signaling pathways are involved in the inhibitory effect of cryptotanshinone on the proliferation of breast cancer SKBR-3 and MCF-7 [16, 17].